Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124307) titled 'Drug survival and treatment response of switching to secukinumab in adalimumab-IR AS patients stratified by anti-drug antibodies: A prospective cohort study' on May 10.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Southern Medical University Southern Hospital
Condition:
Ankylosing spondylitis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-11
Target Sample Size: Ankylosing Spondylitis Observation Group:190;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319963
Published by HT Digital Conte...